CONCLUSION

3/19/01


Click here to start


Table of Contents

CONCLUSION

Conclusion

Efficacy of Celecoxib

Global Improvement Responder

Has the Safety Profile Changed?

Extensive Risk Management Program

NSAID Complications

NSAID WARNING

GI AEs in Labeling

Postmarketing Safety of Sildenafil

PPT Slide

Summary

Consultants

Author: stj11454